23andMe Holding Co. (NASDAQ:ME) Short Interest Down 16.6% in November

23andMe Holding Co. (NASDAQ:ME - Get Free Report) was the recipient of a significant drop in short interest in November. As of November 30th, there was short interest totalling 950,200 shares, a drop of 16.6% from the November 15th total of 1,140,000 shares. Based on an average daily volume of 325,600 shares, the days-to-cover ratio is currently 2.9 days. Approximately 5.9% of the company's shares are sold short.

23andMe Price Performance

Shares of 23andMe stock traded up $0.02 during trading on Friday, hitting $3.35. The company's stock had a trading volume of 141,332 shares, compared to its average volume of 477,644. The stock has a market cap of $87.50 million, a price-to-earnings ratio of -0.13 and a beta of 1.15. 23andMe has a 52 week low of $2.65 and a 52 week high of $20.40. The stock has a 50-day moving average price of $4.33 and a two-hundred day moving average price of $6.58.

23andMe (NASDAQ:ME - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($2.32) EPS for the quarter. 23andMe had a negative net margin of 318.39% and a negative return on equity of 129.98%. The firm had revenue of $44.07 million for the quarter, compared to the consensus estimate of $50.30 million.

Institutional Investors Weigh In On 23andMe

Large investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its stake in 23andMe by 0.7% in the third quarter. Geode Capital Management LLC now owns 4,246,093 shares of the company's stock valued at $1,476,000 after acquiring an additional 28,252 shares during the period. Vanguard Personalized Indexing Management LLC grew its position in 23andMe by 410.4% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 88,555 shares of the company's stock valued at $35,000 after purchasing an additional 71,204 shares during the period. Point72 DIFC Ltd bought a new stake in 23andMe during the 2nd quarter valued at $43,000. Levin Capital Strategies L.P. bought a new position in shares of 23andMe in the second quarter valued at $61,000. Finally, FMR LLC grew its holdings in shares of 23andMe by 24.0% during the third quarter. FMR LLC now owns 993,848 shares of the company's stock valued at $345,000 after buying an additional 192,099 shares during the last quarter. 36.10% of the stock is currently owned by institutional investors and hedge funds.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.